165 related articles for article (PubMed ID: 21030968)
1. FGF23 or PTH: which comes first in CKD ?
Isakova T; Wolf MS
Kidney Int; 2010 Nov; 78(10):947-9. PubMed ID: 21030968
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
4. The PTH-Vitamin D-FGF23 axis.
Blau JE; Collins MT
Rev Endocr Metab Disord; 2015 Jun; 16(2):165-74. PubMed ID: 26296372
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
Damasiewicz MJ; Toussaint ND; Polkinghorne KR
Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
7. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
Nakai K; Komaba H; Fukagawa M
J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. FGF23 and mineral metabolism, implications in CKD-MBD.
Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
[No Abstract] [Full Text] [Related]
10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy.
Westerberg PA; Ljunggren O; Larsson TE; Wadström J; Linde T
Nephrol Dial Transplant; 2010 Dec; 25(12):4068-71. PubMed ID: 20525976
[TBL] [Abstract][Full Text] [Related]
12. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Brown AJ; Slatopolsky E
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
[TBL] [Abstract][Full Text] [Related]
13. [Novel hormones related to the calcium and phosphate homeostasis in kidney disease].
Mace ML; Ølgaard K; Lewin E
Ugeskr Laeger; 2018 May; 180(21):. PubMed ID: 29804564
[TBL] [Abstract][Full Text] [Related]
14. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Drüeke TB
Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
[TBL] [Abstract][Full Text] [Related]
15. [FGF23, a "new" hormone regulating phosphate homeostasis and vitamin D metabolism].
Silve C
Presse Med; 2005 Nov; 34(19 Pt 1):1384-90. PubMed ID: 16292192
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the therapy of secondary hyperparathyroidism.
Wood C; González EA; Martin KJ
Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
[TBL] [Abstract][Full Text] [Related]
18. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
19. [Kidney and bone update : the 5-year history and future of CKD-MBD. CKD-MBD and phosphotropic hormones].
Fukumoto S
Clin Calcium; 2012 Jul; 22(7):987-91. PubMed ID: 22750930
[TBL] [Abstract][Full Text] [Related]
20. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
